SEC Filings

DEF 14A
XTANT MEDICAL HOLDINGS, INC. filed this Form DEF 14A on 12/08/2017
Entire Document
 

 

  

XTANT MEDICAL HOLDINGS, INC.
664 Cruiser Lane
Belgrade, Montana 59714
(406) 388-0480

 

PROXY STATEMENT FOR THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON December 29, 2017

 

QUESTIONS AND ANSWERS ABOUT THE PROXY MATERIALS

 AND THE ANNUAL MEETING

 

Q: Why am I receiving these materials?
   
A: We are providing these proxy materials to you in connection with the Board’s solicitation of proxies for our 2017 Annual Meeting of Stockholders (the “Annual Meeting”), which will take place on December 29, 2017.  As a stockholder of record, you are invited to attend the Annual Meeting and are entitled and requested to vote on the items of business described in this Proxy Statement.  This Proxy Statement and accompanying proxy card (or voting instruction card) are being mailed on or about December 13, 2017 to all stockholders entitled to vote at the Annual Meeting.
   
Q:  When and where will the annual meeting be held?
   
A: The Annual Meeting will be held on December 29, 2017 at 10:00 a.m. Eastern Standard Time, at 112 South Tryon Street, 2nd Floor, Charlotte, North Carolina 28284.
   
Q:  What information is contained in this Proxy Statement?
   
A: This Proxy Statement contains information regarding our corporate governance practices, our board of directors, our named executive officers, the compensation of our board of directors and named executive officers, the proposals to be voted on at the Annual Meeting and certain other required information.
   
Q:  How may I obtain the Company’s Annual Report on Form 10-K for the year ended December 31, 2016?
   
A: We have enclosed with this Proxy Statement a copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.  Our Annual Report on Form 10-K can also be accessed through our website at www.xtantmedical.com (click “Investors” and “SEC Filings”).  We filed our Annual Report on Form 10-K with the Securities and Exchange Commission (the “SEC”) on March 29, 2017.
   
Q:  What items of business will be voted on at the Annual Meeting?
   
A: The items of business scheduled to be voted on at the Annual Meeting are:
   
 

1. To elect two Class III directors to serve on the Board until the 2020 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified;

 

2. To ratify the appointment of EKS&H LLLP (“EKS&H”) as the Company’s independent registered public accounting firm for the year ending December 31, 2017; and

 

3. To transact such other business as may properly be brought before the Annual Meeting and any adjournment or postponement thereof.

   
Q:  How many votes must the nominees for director have to be elected?
   
A: In order for a director to be elected at a meeting at which a quorum is present, he must receive the affirmative vote of a plurality of the shares voted.  There is no cumulative voting for our directors or otherwise.

 

4